By replacing cells to cure a damaged brain, scientists now claim they have managed to slow down and reverse the symptoms of Parkinson's disease.
Laboratory experiments on mice having Parkinson-like symptoms have shown positive results, according to a research published in Nature Biotechnology.
Safety and viability pertaining to the treatment are still being experimented upon by the scientists to make it available for humans.
How does Parkinson's affect people?
Parkinson's disease is a yet-untreatable neurodegenerative disorder.
In this disease patient's brain cells that make dopamine die, creating an imbalance in the brain.
Dopamine deficiency leads to Parkinson's with symptoms like tremors, difficulty in walking, moving and balancing.
The only treatment that doctors can offer is to lessen the symptoms with drugs. Usually, patients belong to the age group 50-60, when symptoms start appearing.
How does Brain Cell Therapy work?
Brain cell therapy aims to replace or repair dead cells to balance the content in the brain and facilitate healthy functioning.
Scientists dealing with Parkinson's disease propose to inject new dopamine-resembling neurones, made out of a mixture of human astrocytes and the cocktail in their laboratory, into the brain so that the dopamine content is restored in order to reverse the process of Parkinson's.
2.5 hours of exercise per week slows down Parkinson's
Researchers at Northwestern University have concluded that exercise of any kind and amount helps with Parkinson's disease.
Slower declines in mobility and overall health quality have been recorded among patients with Parkinson's disease, who regularly exercised for two years.
Researcher Miriam R. Rafferty said, those "who maintained exercise 150 minutes per week had a smaller decline in quality of life and mobility."
Parkinson's more likely if you have Hepatitis B and C
A British study "Viral hepatitis and Parkinson disease" stated that 82% of people suffering from Hepatitis B and 43% of Hepatitis C are likely to be diagnosed with Parkinson's.
The Centers for Disease Control and Prevent estimates around 850,000-2.2 million people suffering from Hepatitis B, while Hepatitis C accounts for 2.7-3.9 million people in America alone at this point.
Parkinson's is the second most common neurodegenerative disorder
A recent study revealed that Parkinson's disease is the second most common neurodegenerative disorder.
The worldwide account for Parkinson's disease stands at 6.3 million people, while every 1 out of 350 people in Australia suffers from Parkinson's.
The study also revealed that every day 30 people are getting diagnosed with Parkinson's in Australia and 60,000 people get diagnosed with Parkinson's every year in America.
Parsi Community of India among the most affected with Parkinson's
Till 2011, India accounted for 7 million people diagnosed with Parkinson's disease.
India reportedly is among the countries with lowest incidence of Parkinson's disease with 70 out of the 100,000 cases worldwide.
The Parsi community of Mumbai has the world's highest incidence of the disease, as 328 Parsis of Mumbai out of every 100,000 people suffer from Parkinson's disease.
Do you know?
James Parkinson, a doctor and a palaeontologist
The person after whom the disease Parkinson's is named was also the first person to establish a connection between fossils and extinct animals. James Parkinson wrote his treatise on Parkinson's in 1817.